I-PHARM CONSULTING LIMITED

Active London

Other activities of employment placement agencies

35 employees website.com
Professional services Other activities of employment placement agencies
I

I-PHARM CONSULTING LIMITED

Other activities of employment placement agencies

Founded 20 Mar 2008 Active London, England 35 employees website.com
Professional services Other activities of employment placement agencies
Accounts Submitted 29 Sept 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 24 Mar 2026 Next due 3 Apr 2027 9 months remaining
Net assets £4M £381K 2024 year on year
Total assets £4M £2M 2024 year on year
Total Liabilities £678K £2M 2024 year on year
Charges 2
2 outstanding

Contact & Details

Contact

Registered Address

Moor Place 1 Fore Street Avenue London EC2Y 9DT England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for I-PHARM CONSULTING LIMITED (06540985), an active professional services company based in London, England. Incorporated 20 Mar 2008. Other activities of employment placement agencies. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type medium
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Balance Sheet & P&L (2014–2024)

Cash in Bank

£1.44M

Increased by £1.19M (+463%)

Net Assets

£3.63M

Decreased by £380.62k (-9%)

Total Liabilities

£678.16k

Decreased by £1.70M (-72%)

Turnover

£9.32M

Decreased by £6.78M (-42%)

Employees

35

Decreased by 15 (-30%)

Debt Ratio

16%

Decreased by 21 (-57%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

2 active 1 resigned
Status
Al-tarafi, Issam AdilDirectorBritishUnited Kingdom5120 Mar 2008Active
Lamport-went, Steven JamesDirectorBritishUnited Kingdom6220 Mar 2008Active

Shareholders

Shareholders (1)

Ipa Talent Group Limited
100.0%
1,143,214

Persons with Significant Control

Persons with Significant Control (2)

2 Active 3 Ceased
Active
Notified 7 Mar 2018
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors
Active
Notified 7 Mar 2018
Nature of Control
  • Ownership Of Shares 75 To 100 Percent
  • Voting Rights 75 To 100 Percent
  • Right To Appoint And Remove Directors

Stephen Peter Mcananey

Ceased 26 Feb 2020

Ceased

Parallel Group Limited

Ceased 7 Mar 2018

Ceased

Parallel Consulting Limited

Ceased 7 Mar 2018

Ceased

Group Structure

Group Structure

I-PHARM CONSULTING LIMITED Current Company

Charges

Charges

2 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
24 Mar 2026Persons With Significant ControlChange to I-Pharm Consulting Group Limited as a person with significant control on 10 Feb 2026
24 Mar 2026Confirmation StatementConfirmation statement made on 20 Mar 2026 with updates
29 Sept 2025AccountsAnnual accounts made up to 31 Dec 2024
28 Mar 2025Confirmation StatementConfirmation statement made on 20 Mar 2025 with updates
11 Feb 2025OfficersTermination of Colin John Lynam as director on 31 Jan 2025
24 Mar 2026 Persons With Significant Control

Change to I-Pharm Consulting Group Limited as a person with significant control on 10 Feb 2026

24 Mar 2026 Confirmation Statement

Confirmation statement made on 20 Mar 2026 with updates

29 Sept 2025 Accounts

Annual accounts made up to 31 Dec 2024

28 Mar 2025 Confirmation Statement

Confirmation statement made on 20 Mar 2025 with updates

11 Feb 2025 Officers

Termination of Colin John Lynam as director on 31 Jan 2025

Recent Activity

Latest Activity

Change to I-Pharm Consulting Group Limited as a person with significant control on 10 Feb 2026

2 months ago on 24 Mar 2026

Confirmation statement made on 20 Mar 2026 with updates

2 months ago on 24 Mar 2026

Annual accounts made up to 31 Dec 2024

8 months ago on 29 Sept 2025

Confirmation statement made on 20 Mar 2025 with updates

1 years ago on 28 Mar 2025

Termination of Colin John Lynam as director on 31 Jan 2025

1 years ago on 11 Feb 2025